Literature DB >> 6602726

Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.

O Niemelä, L Risteli, E A Sotaniemi, J Risteli.   

Abstract

An assay of serum antigens related to the aminoterminal propeptide of type III procollagen has been suggested for monitoring fibrotic processes in the liver. These antigens were measured here in 61 alcoholics who were divided into four groups on the basis of liver histology: normal light microscopy, fatty liver, alcoholic cirrhosis with hepatitis, and inactive cirrhosis. All the subjects having alcoholic hepatitis with cirrhosis had elevated values in the assay, whereas some of those with either fatty liver or inactive cirrhosis still had normal values. It was, therefore, not possible on the basis of this method alone to distinguish fatty liver from cirrhosis or alcoholic hepatitis, although very high values were suggestive of alcoholic hepatitis. In a follow-up study, the aminopropeptide value decreased slowly during recovery from alcoholic hepatitis and increased rapidly after a new drinking bout. The antigens detected by the assay are heterogeneous in human serum. The proportions of the three main peptide forms varied during recovery from alcoholic hepatitis, the authentic propeptide being the main one at the acute stage, but almost disappearing later. The usefulness of the assay could probably be improved if distinct assays were available for the different antigen forms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602726

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Type I and type III procollagen peptides during hepatic fibrogenesis. An immunohistochemical and ELISA serum study in the CCl4 rat model.

Authors:  B H Davis; J A Madri
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

2.  Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders.

Authors:  K Hørslev-Petersen; K D Bentsen; P Junker; F K Mathiesen; T M Hansen; I Lorenzen
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

3.  An immunohistochemical and serum ELISA study of type I and III procollagen aminopropeptides in primary biliary cirrhosis.

Authors:  B H Davis; J A Madri
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

4.  Alcoholic liver disease in the 1980s.

Authors:  J B Saunders
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

5.  Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis.

Authors:  E R Savolainen; D Brocks; L Ala-Kokko; K I Kivirikko
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

Review 6.  A review of new approaches to assessing hepatic function in animals.

Authors:  C E Cornelius
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

7.  Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?

Authors:  C Surrenti; A Casini; S Milani; S Ambu; P Ceccatelli; A D'Agata
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

8.  Purification and characterization of the N-terminal propeptide of human type III procollagen.

Authors:  O Niemelä; L Risteli; J Parkkinen; J Risteli
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

9.  Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis.

Authors:  H Nakano; H Nakabayashi; Y Okamoto; T Kawasaki; S Seko; Y Fukuda
Journal:  Gastroenterol Jpn       Date:  1985-12

10.  Serum laminin--its concentration increases with portal hypertension in cirrhotic liver disease.

Authors:  A M Gressner; W Tittor
Journal:  Klin Wochenschr       Date:  1986-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.